Palisade Bio (PALI) Net Margin (2011 - 2023)

Palisade Bio (PALI) has 11 years of Net Margin data on file, last reported at 936.0% in Q1 2023.

• Net Margin for Q1 2023 came in at 936.0%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was 5070.8% (changed N/A YoY), and the FY2023 annual result was 5234.0%, changed N/A from the prior year.
• Net Margin grew to 936.0% in Q1 2023 per PALI's latest filing, from 169760.0% in the prior quarter.
• Over five years, Net Margin peaked at 936.0% in Q1 2023 and troughed at 169760.0% in Q4 2020.
• A 3-year average of 71345.21% and a median of 74040.0% in 2020 frame the typical range for Net Margin.
• On a YoY basis, Net Margin climbed as much as 6429700 bps in 2020 and fell as far as 8478356 bps in 2020.
• A 3-year view of Net Margin shows it stood at 84976.44% in 2019, then plunged by 100 bps to 169760.0% in 2020, then surged by 99 bps to 936.0% in 2023.
• Business Quant data shows PALI's Net Margin at 936.0% in Q1 2023, 169760.0% in Q4 2020, and 73720.0% in Q3 2020.